High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.1M
$4,116,973
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| TRDA |
Entrada Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-10 | $155,188 | S | Form 4 |
| TRDA |
Entrada Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-10 | $148,216 | S | Form 4 |
| TRDA |
Entrada Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-09 | $40,583 | S | Form 4 |
| TRDA |
Entrada Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-09 | $66,163 | S | Form 4 |
| TRDA |
Entrada Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-04 | $97,892 | S | Form 4 |
| TRDA |
Entrada Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-21 | $88,932 | S | Form 4 |
|
TRDA
S
Entrada Therapeutics, Inc.
5AM Ventures V, L.P.
• 10% Owner
Discretionary Sell
2025-11-14
$1,760,000Large
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
10% Owner
Discretionary Sell
|
2025-11-14 | $1,760,000Large | S | Form 4 |
|
TRDA
S
Entrada Therapeutics, Inc.
PARMAR KUSH
• Director
Discretionary Sell
2025-11-14
$1,760,000Large
|
||||||
| TRDA |
Entrada Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-11-14 | $1,760,000Large | S | Form 4 |